Related Experiment Videos
Coexisting systemic lupus erythematosus and sickle cell disease: a diagnostic and therapeutic challenge
Nader A Khalidi1, Harpinder Ajmani, John Varga
1Section of Rheumatology, McMaster University, 240 James Street South, Hamilton, Ontario, Canada L8P 3B3. naderkhalidi@sympatico.ca
Insights
Systemic lupus erythematosus (SLE) and sickle cell disease (SCD) can coexist, though rarely. Diagnosing SLE in SCD patients is challenging due to overlapping symptoms, potentially delaying crucial treatment.
Area of Science:
- Rheumatology
- Hematology
- Internal Medicine
Background:
- Systemic lupus erythematosus (SLE) and sickle cell disease (SCD) are prevalent disorders, particularly in Black populations.
- The co-occurrence of SLE and SCD in a single patient is exceptionally rare.
- This study investigates the complexities of managing patients with both conditions.
Observation:
- Four cases of concurrent SLE and SCD are presented.
- Patients exhibited diverse complications affecting musculoskeletal, central nervous system, and renal systems.
- Clinical manifestations often overlapped between SLE and SCD.
Findings:
- Diagnosing SLE in patients with SCD is frequently delayed due to overlapping symptoms.
- A significant proportion of SCD patients (up to 23%) may present with antinuclear antibodies.
- All reported patients had pre-existing SCD, but developed significant new complications attributed to SLE.
Implications:
- Recognizing the diagnostic challenges is crucial for timely SLE diagnosis in SCD patients.
- Increased awareness of potential SLE complications in SCD patients is warranted.
- Further research is needed to elucidate the interplay between SLE and SCD and optimize patient management.
Abstract:
Systemic lupus erythematosus (SLE) and sickle cell disease (SCD) are relatively common disorders with comparable prevalence among blacks. The coexistence of these 2 conditions in the same individual appears to be rare. We report 4 cases of coexisting SLE and SCD. These patients displayed a broad spectrum of musculoskeletal, central nervous system, and renal complications that may be associated with either SCD or SLE. Because of a substantial overlap between the clinical manifestations of these 2 disorders, the diagnosis of SLE in patients with SCD may be difficult to establish and is often delayed. Up to 23% of patients with SCD may have antinuclear antibodies. All patients in this series had antecedent SCD but new important complications from SLE.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations